Copyright
©The Author(s) 2025.
World J Hepatol. May 27, 2025; 17(5): 105890
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.105890
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.105890
Table 4 Clinical outcomes of the two subgroups of reoperative left hemihepatectomy
Clinical outcomes | Reoperative open left hemihepatectomy (n = 33) | Reoperative laparoscopic left hemihepatectomy (n = 50) | χ²/t/Z value | P value |
Selective hepatic blood flow occlusion | 29/33 (87.9) | 47/50 (94.0) | 0.956 | 0.3261 |
Operation duration, mean (SD), minute | 244.7 (84.7) | 318.9 (88.5) | -3.800 | 0.0002 |
Blood loss, median (IQR), mL | 235.7 (150.0-400.0) | 200.0 (100.0-400.0) | -1.411 | 0.1583 |
Blood transfusion | 13/33 (39.4) | 11/50 (22.0) | 2.926 | 0.0871 |
Conversion to open surgery | - | 8/50 (16.0) | - | - |
Postoperative intensive care unit stay | 5/33 (15.2) | 10/50 (20.0) | 0.316 | 0.5741 |
Postoperative hospital stay, median (IQR), days | 13.0 (8.0-21.0) | 8.0 (7.0-12.3) | -3.237 | 0.0013 |
Early complications within 90 days | 21/33 (63.6) | 27/50 (54.0) | 0.757 | 0.3841 |
Major complications within 90 days | 1/33 (3.0) | 3/50 (6.0) | N/A4 | 1.000 |
Reinterventions within 90 days | 1/33 (3.0) | 3/50 (6.0) | N/A4 | 1.000 |
Readmission within 90 days | 6/33 (18.2) | 10/50 (20.0) | 0.042 | 0.8371 |
90-day mortality | 0/33 (0.0) | 0/50 (0.0) | - | - |
Initial stone clearance rate5 | 25/32 (78.1) | 36/48 (75.0) | 0.104 | 0.7481 |
Re-treatment of residual stones5 | 4/32 (12.5) | 6/48 (12.5) | N/A3 | 1.000 |
Final stone clearance rate5 | 26/32 (81.3) | 39/48 (81.3) | 0.000 | 1.0001 |
Stone recurrence6 | 8/26(30.8 ) | 2/39 (5.1) | N/A4 | 0.011 |
Late complications5 | 4/32 (12.5) | 3/48 (6.3) | N/A4 | 0.429 |
Late major complications5 | 2/32 (6.3) | 1/48 (2.1) | N/A4 | 0.561 |
Secondary ICC5 | 0/32 (0.0) | 0/48 (0.0) | - | - |
Late death due to complications or ICC5 | 1/32 (3.1) | 0/48 (0.0) | N/A4 | 0.400 |
- Citation: Zhang WJ, Chen G, Dai DF, Chen XP. Not all reoperative laparoscopic liver resection procedures are feasible for hepatolithiasis patients with a history of biliary surgery. World J Hepatol 2025; 17(5): 105890
- URL: https://www.wjgnet.com/1948-5182/full/v17/i5/105890.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i5.105890